Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001659617-19-000144
Filing Date
2019-08-16
Accepted
2019-08-16 17:16:38
Documents
54
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mbx-20190630.htm   iXBRL 10-Q 1236323
2 EX-31.1 a2019q2ex311-xnextgen.htm EX-31.1 12226
3 EX-31.2 a2019q2ex312-xnextgen.htm EX-31.2 11914
4 EX-32.1 a2019q2ex321-xnextgen.htm EX-32.1 7055
5 EX-32.2 a2019q2ex322-xnextgen.htm EX-32.2 7132
11 mbx-20190630_g1.jpg GRAPHIC 132868
  Complete submission text file 0001659617-19-000144.txt   6140445

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mbx-20190630.xsd EX-101.SCH 43228
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mbx-20190630_cal.xml EX-101.CAL 53163
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mbx-20190630_def.xml EX-101.DEF 204600
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mbx-20190630_lab.xml EX-101.LAB 518343
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mbx-20190630_pre.xml EX-101.PRE 333595
12 EXTRACTED XBRL INSTANCE DOCUMENT mbx-20190630_htm.xml XML 962097
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

EIN.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37758 | Film No.: 191034199
SIC: 2834 Pharmaceutical Preparations